Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04788108
Status:
COMPLETED
Last Update Posted:
2023-08-30
First Post:
2021-03-02
Brief Title:
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
Sponsor:
Chulalongkorn University
Organization:
Chulalongkorn University
Study Overview
Official Title:
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion a Randomized Double-blinded Placebo-controlled Trial
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion Half of participants will receive oral dydrogesterone while the other half will receive oral placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None